Strohmaier W L
Klinik für Urologie und Kinderurologie, Klinikum, Coburg.
Urologe A. 2006 Nov;45(11):1406-9. doi: 10.1007/s00120-006-1220-6.
The calculation model which we developed for the cost of stone therapy and metaphylaxis in Germany some years ago with a social health insurance company is based on estimates of stone incidence, types and recurrence rates, actual costs for stone removal, and metaphylaxis (based on data from a district of the social health care system). There are 200,000 stone recurrences per year in Germany. Costs for treatment of these stones amount to $687,000,000. Stone metaphylaxis reduces the recurrence rate by some 40%. The annual cost for stone removal could be lowered by $275,300,000. Metabolic evaluation/metaphylaxis amount to $70,100,000 per year, resulting in a net saving of $205,200,000. In 1997, there were 96 days off work per stone patient resulting in 5,800,000 days off work in Germany per year. Metaphylaxis is not only medically effective in stone formers but also can lower health care cost significantly. Although health care conditions may vary from country to country, in principle this calculation model is applicable also to other countries.
几年前,我们与一家社会健康保险公司合作,为德国的结石治疗和预防成本开发了一种计算模型。该模型基于结石发病率、类型和复发率的估计、结石清除的实际成本以及预防措施(基于社会医疗保健系统一个地区的数据)。德国每年有20万例结石复发。治疗这些结石的费用达6.87亿美元。结石预防措施可使复发率降低约40%。每年的结石清除费用可降低2.753亿美元。代谢评估/预防措施每年花费7010万美元,从而实现净节省2.052亿美元。1997年,每位结石患者每年有96天缺勤,德国每年因此有580万天的缺勤。预防措施不仅对结石患者具有医学上的有效性,还能显著降低医疗成本。尽管各国的医疗保健情况可能有所不同,但原则上该计算模型也适用于其他国家。